471 filings
Page 7 of 24
8-K
5a3wp5y
14 May 19
Other Events
8:00am
8-K
w8oc sazo17utu
8 May 19
Lipocine Announces First Quarter 2019 Financial and Operational Results
8:02am
8-K
6jyp5ouq8yr iiu00x
1 May 19
Other Events
8:01am
8-K
986fd2llj9qh
11 Apr 19
Other Events
8:00am
8-K
vbe0tg
3 Apr 19
Other Events
9:30am
8-K
369xho9u
28 Mar 19
Other Events
8:00am
8-K
e90rjrl kj
27 Mar 19
Lipocine Announces ABPM Labeling Study Results Consistent with Recently Approved Testosterone Replacement Therapy
8:00am
8-K
m22q06u6if 6j
26 Mar 19
Other Events
8:00am
8-K
potfga
18 Mar 19
Other Events
8:00am
8-K
cucnkvh8ii
12 Mar 19
Other Events
8:00am
8-K
gnrck 4et4
7 Mar 19
Other Events
8:00am
8-K
l4dfu 1xc
6 Mar 19
Fourth Quarter 2019 and Recent Corporate Highlights
8:01am
8-K
34vx5kfm1pqaxtffw
14 Feb 19
Lipocine Inc. Announces FDA Clearance of IND to Commence Phase 2 Study of LPCN 1144 in Biopsy Confirmed NASH Subjects
7:00am
8-K
23ja7f431oz9m q0vu
28 Jan 19
Other Events
8:01am
8-K
3wgyy3t2ve
24 Jan 19
Other Events
8:01am
8-K
j4ro322rrhy9u89lu
22 Jan 19
Other Events
8:00am
8-K
2p1qv22 1xv
17 Jan 19
Lipocine’s NASH Therapy Candidate Achieves Meaningful Liver Fat Reduction Based on Interim Results
7:00am